Target intelligence / Profile preview

Pseudogene similar to part of ribosomal protein L10

Molecular classification
Other
01

Overview

ENSG00000236450, also known as AL590399.6 or "pseudogene similar to part of ribosomal protein L10 (RPL10)," is annotated as a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise by gene duplication or retrotransposition and lose their protein-coding ability or regulatory function. This pseudogene is named for its sequence similarity to the ribosomal protein L10 (RPL10), but it does not encode a functional protein. This entry is a pseudogene, not a protein-coding gene, enzyme, receptor, transporter, or recognized drug target. Pseudogenes like this are generally considered non-functional with respect to coding for a protein or serving as a therapeutic target. There are no known drugs, disease roles, or established biological functions associated with this pseudogene. Its primary significance is as a non-coding genomic sequence similar in part to ribosomal protein L10, which itself is a structural protein component of the ribosome, but the pseudogene form does not share those functions. Because this entry is not a conventional or functional drug target and has no known therapeutic, functional, or diagnostic use, the fields for biological functions, disease roles, drugs, mechanisms, biomarkers, and safety concerns are all null or not applicable. This target is thus considered "incorrect" in the context of a therapeutic target or functional protein request.

Other names
AL590399.6Pseudogene Similar To Part Of Ribosomal Protein L10 (RPL10)

Beyond the preview

Go deeper on Pseudogene similar to part of ribosomal protein L10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of ribosomal protein L10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call